Tag: Prescription Drugs
Buprenorphine Rx Activity Varies Widely Among Clinicians
Less than 5 percent of prescribers account for half of all buprenorphine treatment in the country
ACC: Ultrasound Renal Denervation Cuts BP in Med-Resistant HTN
Reduction in daytime ambulatory systolic blood pressure at two months greater with ultrasound renal denervation versus sham procedure
Upadacitinib Treats Moderate-to-Severe Atopic Dermatitis
Two replicate double-blind, randomized, placebo-controlled trials show short-term efficacy for upadacitinib in adolescents and adults
CDC: Self-Administered Subcutaneous DMPA Should Be Made Available
WHO recommendation adopted based on evidence that self-administered DMPA-SC is safe, effective with higher continuation rates
Meds Used for Hospitalized COVID-19 Patients Shifted Over 2020
Dexamethasone and remdesivir use grew substantially, while azithromycin and hydroxychloroquine both declined from early peaks
Key Factors ID’d for Bipolar Medication Nonadherence
Patients report side effects, beliefs, and knowledge about bipolar disorder are top reasons for not taking medications
Intensive BP Lowering Cuts Major Adverse CV Events, Mortality
But adverse effects, including hypotension, acute kidney injury, syncope, more frequent with intensive treatment in those at increased CV risk
Rituximab, Mycophenolate Mofetil Compared for Pemphigus Vulgaris
More patients receiving rituximab versus mycophenolate mofetil had sustained complete remission at week 52, fewer had disease flares
Infliximab May Reduce Immunogenicity to SARS-CoV-2 Vaccine
Antibody concentrations lower in infliximab-treated individuals with IBD receiving single dose of BNT162b2 or ChAdOx1 nCoV-19 vaccine
Brand-Name Competition for Diabetes Drugs Has Variable Impact on Net Prices
And, one in five generic drugs sold in U.S. experienced price spikes initiated by manufacturers during 2014 to 2017